[go: up one dir, main page]

MY161034A - Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk - Google Patents

Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Info

Publication number
MY161034A
MY161034A MYPI2013701285A MYPI2013701285A MY161034A MY 161034 A MY161034 A MY 161034A MY PI2013701285 A MYPI2013701285 A MY PI2013701285A MY PI2013701285 A MYPI2013701285 A MY PI2013701285A MY 161034 A MY161034 A MY 161034A
Authority
MY
Malaysia
Prior art keywords
bifidobacteria
growth
modulation
combination
human milk
Prior art date
Application number
MYPI2013701285A
Inventor
David Curtis Frantz
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45809349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY161034(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MY161034A publication Critical patent/MY161034A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A PREBIOTIC FORMULATION FOR ORAL ADMINISTRATION TO A HUMAN COMPRISING 2'-FUCOSYLLACTOSE, 3'-SIALYLLACTOSE AND 6'-SIALYLLACTOSE, AND A METHOD FOR MODULATING OR STIMULATING THE GROWTH OF BIFIDOBACTERIA IN THE GUT. THE FORMULATION MAY BE AN INFANT FORMULA.
MYPI2013701285A 2011-02-10 2012-02-03 Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk MY161034A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161441451P 2011-02-10 2011-02-10

Publications (1)

Publication Number Publication Date
MY161034A true MY161034A (en) 2017-04-14

Family

ID=45809349

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013701285A MY161034A (en) 2011-02-10 2012-02-03 Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Country Status (19)

Country Link
US (3) US20140371173A1 (en)
EP (2) EP2672844B2 (en)
CN (2) CN104126749A (en)
AU (1) AU2012215042B2 (en)
BR (1) BR112013020108A2 (en)
CA (1) CA2825697A1 (en)
CL (1) CL2013002210A1 (en)
ES (2) ES2527200T5 (en)
IL (1) IL227487A (en)
MX (2) MX362129B (en)
MY (1) MY161034A (en)
PH (1) PH12013501501A1 (en)
PL (1) PL2672844T3 (en)
PT (1) PT2672844E (en)
RU (1) RU2586928C2 (en)
SG (1) SG192095A1 (en)
TW (1) TW201244640A (en)
WO (1) WO2012107865A2 (en)
ZA (1) ZA201306751B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104126749A (en) 2011-02-10 2014-11-05 雀巢产品技术援助有限公司 Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
WO2013154725A1 (en) * 2012-04-13 2013-10-17 Trustees Of Boston College Prebiotic compositions and methods of use
EP2708145B1 (en) 2012-09-14 2016-05-04 Abbott Laboratories Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
SG11201608248YA (en) 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
DK3209308T3 (en) * 2014-10-24 2022-10-03 Evolve Biosystems Inc ACTIVATED BIFIDOBACTERIA AND METHODS OF USING THEREOF
MX2017006701A (en) * 2014-11-26 2018-02-13 Abbott Lab Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic.
RU2706963C2 (en) * 2014-11-26 2019-11-21 Абботт Лаборэтриз Milk mixture containing breast milk oligosaccharides, polyunsaturated fatty acids, nucleotides and lutein
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
CN107106584A (en) 2014-12-08 2017-08-29 格礼卡姆股份公司 Synthetic compositions for treating metabolic disorders
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
PH12017550039B1 (en) * 2015-03-05 2022-07-20 Socia‰Ta‰ Des Produits Nestla‰ S A Compositions for use in improving stool consistency or frequency in infants or young children
WO2017071716A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US10835545B2 (en) 2015-10-28 2020-11-17 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
CN108541221B (en) * 2015-12-15 2023-02-28 格礼卡姆股份公司 Mixtures of HMOs
CN109561724A (en) 2016-06-21 2019-04-02 阿拉食品公司 The product for producing the method for the improvement nutrition product containing lactoprotein and lactose class and being obtained by this method
EP3490567A4 (en) * 2016-07-28 2020-03-18 Fonterra Co-Operative Group Limited Dairy product and process
RU2740156C1 (en) * 2017-06-21 2021-01-12 Эбботт Лабораториз Methods for improving growth of useful bacteria in gastrointestinal tract
CN111683665A (en) * 2017-11-30 2020-09-18 格礼卡姆股份公司 Human milk oligosaccharides for microbiota modulation and their synthetic compositions
CN113950247A (en) * 2019-06-05 2022-01-18 森永乳业株式会社 Composition comprising a metal oxide and a metal oxide
JP7474596B2 (en) * 2020-01-20 2024-04-25 森永乳業株式会社 Novel Bifidobacterium bacteria, compositions containing said bacteria, and compositions for promoting the growth of said bacteria

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260280A (en) 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JP2003522784A (en) * 2000-02-17 2003-07-29 ワイス Nutritional formulations containing prebiotic substances
WO2001060246A2 (en) * 2000-02-18 2001-08-23 Argose, Inc. Multivariate analysis of green to ultraviolet spectra of cell and tissue samples
US6913778B2 (en) 2001-12-21 2005-07-05 Wyeth Infant formula compositions comprising increased amounts of alpha-lactalbumin
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
WO2004112509A2 (en) 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
MXPA06006392A (en) † 2003-12-05 2007-03-15 Childrens Hosp Medical Center Oligosaccharide compositions and use thereof in the treatment of infection.
EP1951060B1 (en) 2005-11-04 2017-11-01 Arla Foods Amba A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) † 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
NL2001377C2 (en) 2008-03-14 2009-09-15 Friesland Brands Bv Process for isolating sialic acid-containing oligosaccharides, as well as the compositions containing sialic acid-containing oligosaccharides.
IN2012DN00282A (en) * 2009-07-31 2015-05-08 Nestec Sa
NL2004200C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
EP2563165A1 (en) * 2010-04-27 2013-03-06 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
NZ612386A (en) * 2010-12-31 2015-02-27 Abbott Lab Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
CN104126749A (en) 2011-02-10 2014-11-05 雀巢产品技术援助有限公司 Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Also Published As

Publication number Publication date
MX345413B (en) 2017-01-27
MX2013009087A (en) 2013-09-13
WO2012107865A2 (en) 2012-08-16
IL227487A0 (en) 2013-09-30
EP2792252A3 (en) 2015-03-25
CL2013002210A1 (en) 2014-01-10
ES2527200T3 (en) 2015-01-21
EP2672844A2 (en) 2013-12-18
WO2012107865A3 (en) 2012-11-01
RU2013141449A (en) 2015-03-20
ZA201306751B (en) 2015-05-27
PT2672844E (en) 2015-02-04
CA2825697A1 (en) 2012-08-16
BR112013020108A2 (en) 2017-06-13
US20140371173A1 (en) 2014-12-18
PL2672844T3 (en) 2015-04-30
RU2586928C2 (en) 2016-06-10
IL227487A (en) 2015-10-29
EP2792252A2 (en) 2014-10-22
TW201244640A (en) 2012-11-16
ES2527200T5 (en) 2022-12-29
ES2692533T3 (en) 2018-12-04
MX362129B (en) 2019-01-07
EP2672844B1 (en) 2014-11-19
PH12013501501A1 (en) 2019-10-07
US20120208782A1 (en) 2012-08-16
SG192095A1 (en) 2013-08-30
EP2672844B2 (en) 2022-10-05
CN104126749A (en) 2014-11-05
AU2012215042B2 (en) 2016-01-14
CN103347405A (en) 2013-10-09
US20150141367A1 (en) 2015-05-21
EP2792252B1 (en) 2018-09-12

Similar Documents

Publication Publication Date Title
MY161034A (en) Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
HK1218560A1 (en) Compositions and methods
NZ613180A (en) Methods of using human milk oligosaccharides for improving airway respiratory health
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
MX362626B (en) Methods of treating pediatric patients using dexmedetomidine.
NZ612504A (en) Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
NZ612105A (en) Human milk oligosaccharides for modulating inflammation
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
NZ612386A (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MY173215A (en) Acetylcysteine compositions and methods of use thereof
MX344238B (en) Tetrazole compounds and methods of making and using same.
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
NZ701607A (en) Therapeutic use of chardonnay seed products
MX2018004616A (en) Cosmetic composition having probiotic bacteria.
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2014110353A9 (en) Notch ligand bound biocompatible substrates and their use in bone formation
WO2011044523A3 (en) Compositions and methods for treating obesity
CA2899775C (en) Compositions and methods for pain relief without numbness
GB201200858D0 (en) Prebiotic powder composition and uses thereof
EA201390417A1 (en) ANTI-DIABETIC SOLID PHARMACEUTICAL COMPOSITIONS
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
PH12014501822A1 (en) Oral formulation comprising lansoprazole and the preparation method thereof
MX2009011214A (en) Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin -4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas.
梁凌智 Preliminary study of smile correlative esthetic factors
UA74544U (en) method for treatment and prevention of chronic generalized periodontitis